Logo

American Heart Association

  34
  0


Final ID:

Development and evolution of novel genome engineering technologies

  • Newby, Gregory  ( John Hoplkins , Baltimore , Maryland , United States )
  • Gaudelli, Nicole  ( Google Ventures , Cambridge , Massachusetts , United States )
  • Liu, David  ( Harvard University , Boston , Massachusetts , United States )
  • Author Disclosures:
    Gregory Newby: No Answer | Nicole Gaudelli: No Answer | David Liu: No Answer
Meeting Info:

Scientific Sessions 2025

2025

New Orleans, Louisiana

Session Info:

Transformative Advances in Genome Engineering for Precision Therapy

Saturday, 11/08/2025 , 09:45AM - 11:00AM

Cardiovascular Seminar

More abstracts on this topic:
Ethical considerations of gene editing technologies

Magnus David, Tabort Holly, Saha Krishanu

Developing single course in vivo gene editing therapies for hyperlipidemia

Kathiresan Sekar, Musunuru Kiran, Ishikawa Kiyotake

More abstracts from these authors:
Regulatory Profiling of LMNA Identifies Therapeutic Targets for LMNA-Associated Dilated Cardiomyopathy

Viskadourou Maria, Beer Michael, Newby Gregory, Rojnuckarin Andrew, Xiao Jinghan, Saba Nicholas, Shoppell Elyse, Eckley D. Mark, Yates Bradley, Kim Yuri, Watkins Hugh

You have to be authorized to contact abstract author. Please, Login
Not Available